Table of Contents
SBI Contra Fund and Invesco India Contra Fund both belong to the equity category of Mutual Funds. Both the funds follow a contrarian investment strategy. contra funds are a type of Equity Fund where the fund manager bets against the prevailing Market trends by buying assets that are either depressed or under-performing at that point in time. A contrarian is an investment strategy where the fund manager keeps a strong watch on the market to identify those underperforming stocks which have great potential to grow in the future. To guide you in making a better investment decision, we have done a comparison between both SBI Contra Fund and Invesco India Contra Fund. Take a look!
SBI Contra Fund was launched in the year July 14, 1999, with an aim to provide a long-term Capital appreciation to the investors through contrarian Investing. Being an equity-oriented fund, SBI Contra Fund is suitable for investors with a high-risk appetite. As an investment strategy, SBI Contra Fund follows a combination of top-down and bottom-up approach to stock-picking. Some of the top holdings of the fund as on 31/05/2018 are Kotak Mahindra Bank Ltd, Bharti Airtel Ltd, Eigi Equipments Ltd, ICICI Bank Ltd, etc. SBI Contra Fund is currently managed by Dinesh Balachandran. The fund follows S&P BSE 500 Index as its benchmark.
Invesco India Contra Fund was launched in the year April 11, 2007. The fund aims to seek long-term capital appreciation by investing in equity and related instruments through contrarian investing. The fund invests its corpus in sound companies which are available at attractive valuations/undervalued or in turnaround phase. As on Jun 30, 2018 some of the top holdings of the scheme are HDFC Bank Ltd, Reliance Industries Ltd, Infosys Ltd, ICICI Bank Ltd, ITC Ltd, etc. Invesco India Contra Fund is jointly managed by Taher Badshah and Amit Ganatra.
Though these schemes belong to the same category, yet these schemes differ on various parameters. So, let us understand the parameters which are divided into four sections, namely, Basics Section, Performance Report, Yearly Performance Report, and Other Details Section.
This section compares the various elements such as Current NAV, Scheme Category, and Fincash Rating. To begin with the scheme category, it can be said that both the schemes SBI Contra Fund and Invesco India Contra Fund belong to the same category of equity fund. With respect to the next parameter, that is, Fincash Rating, it can be said that SBI Contra Fund is rated as 3-Star, whereas Invesco India Contra Fund is rated as 4-Star. In case of Net Asset Value, SBI Contra Fund's NAV as on 19th July 2018 is INR 106.675 and the NAV of Invesco India Contra Fund is INR 46.39. The table given below summarizes the details of basics section.
Parameters Basics NAV Net Assets (Cr) Launch Date Rating Category Sub Cat. Category Rank Risk Expense Ratio Sharpe Ratio Information Ratio Alpha Ratio Benchmark Exit Load SBI Contra Fund
Growth
Fund Details ₹267.29 ↑ 0.94 (0.35 %) ₹13,461 on 31 Jul 23 6 May 05 ☆☆☆ Equity Contra 48 Moderately High 1.92 2.09 2.34 12.15 Not Available 0-1 Years (1%),1 Years and above(NIL) Invesco India Contra Fund
Growth
Fund Details ₹89.03 ↑ 0.34 (0.38 %) ₹11,025 on 31 Jul 23 11 Apr 07 ☆☆☆☆ Equity Contra 11 Moderately High 1.8 0.99 -0.71 1.58 Not Available 0-1 Years (1%),1 Years and above(NIL)
The performance section compares the Compounded Annual Growth Rate or CAGR returns between both the schemes at different time periods. With respect to performance, it can be said there is not much difference in the performance of both the schemes. However, in many instances, SBI Contra Fund leads the race. The performance of both the schemes at different time periods is shown below as follows.
Parameters Performance 1 Month 3 Month 6 Month 1 Year 3 Year 5 Year Since launch SBI Contra Fund
Growth
Fund Details 1% 11.9% 17.5% 23.9% 36.1% 18.7% 16.5% Invesco India Contra Fund
Growth
Fund Details 1.1% 10.3% 14.8% 15.3% 21.2% 12.3% 14.3%
Talk to our investment specialist
This section deals with the absolute returns generated by both the funds in each year. In this case, we can see that there is a difference in the performance of both the schemes. In many situations, Invesco India Contra Fund has performed better than SBI Contra Fund. The yearly performance of both the funds is tabulated as follows.
Parameters Yearly Performance 2022 2021 2020 2019 2018 SBI Contra Fund
Growth
Fund Details 12.8% 49.9% 30.6% -1% -14.3% Invesco India Contra Fund
Growth
Fund Details 3.8% 29.6% 21.2% 5.9% -3.3%
This is the last section in the comparison of both the funds. In this section, the parameters such as AUM, Minimum SIP and Lumpsum Investment, and Exit Load are compared. To begin with the minimum SIP investment, both the schemes have the same monthly SIP amounts, i.e., INR 500. Similarly, in case of minimum lumpsum investment, the amount for both the schemes are same i.e, INR 5,000. Coming to the AUM, the AUM of SBI Contra Fund as on 30th June 2018 was INR 1,605 crores and the AUM of Invesco India Contra Fund was INR 1,868 crores. The table given below summarizes the other details for both the schemes.
Parameters Other Details Min SIP Investment Min Investment Fund Manager SBI Contra Fund
Growth
Fund Details ₹500 ₹5,000 Dinesh Balachandran - 5.32 Yr. Invesco India Contra Fund
Growth
Fund Details ₹500 ₹5,000 Taher Badshah - 6.63 Yr.
SBI Contra Fund
Growth
Fund Details Growth of 10,000 investment over the years.
Date Value 31 Aug 18 ₹10,000 31 Aug 19 ₹8,357 31 Aug 20 ₹9,034 31 Aug 21 ₹15,940 31 Aug 22 ₹18,872 31 Aug 23 ₹23,501 Invesco India Contra Fund
Growth
Fund Details Growth of 10,000 investment over the years.
Date Value 31 Aug 18 ₹10,000 31 Aug 19 ₹8,900 31 Aug 20 ₹9,845 31 Aug 21 ₹14,857 31 Aug 22 ₹15,703 31 Aug 23 ₹17,846
SBI Contra Fund
Growth
Fund Details Asset Allocation
Asset Class Value Cash 16.63% Equity 83.37% Equity Sector Allocation
Sector Value Financial Services 18.41% Basic Materials 11.74% Industrials 11.6% Technology 7.9% Health Care 7.89% Utility 7.75% Energy 6.59% Consumer Cyclical 5.86% Consumer Defensive 3.76% Real Estate 0.95% Communication Services 0.92% Top Securities Holdings / Portfolio
Name Holding Value Quantity Cognizant Technology Solutions Corp Class A (Technology)
Equity, Since 28 Feb 23 | CTSH3% ₹491 Cr 828,500 HDFC Bank Ltd (Financial Services)
Equity, Since 31 Aug 16 | HDFCBANK3% ₹446 Cr 2,837,072 GAIL (India) Ltd (Utilities)
Equity, Since 28 Feb 21 | 5321553% ₹428 Cr 37,211,295 Coforge Ltd (Technology)
Equity, Since 31 Aug 23 | COFORGE2% ₹320 Cr 585,000
↑ 585,000 Delhivery Ltd (Industrials)
Equity, Since 31 Oct 22 | 5435292% ₹313 Cr 7,156,013 ICICI Bank Ltd (Financial Services)
Equity, Since 28 Feb 17 | ICICIBANK2% ₹301 Cr 3,140,345 182 DTB 29092023
Sovereign Bonds | -2% ₹298 Cr 30,000,000 91 DTB 09112023
Sovereign Bonds | -2% ₹296 Cr 30,000,000
↑ 30,000,000 91 DTB 17112023
Sovereign Bonds | -2% ₹296 Cr 30,000,000
↑ 30,000,000 Axis Bank Ltd (Financial Services)
Equity, Since 31 May 19 | 5322152% ₹292 Cr 3,004,255 Invesco India Contra Fund
Growth
Fund Details Asset Allocation
Asset Class Value Cash 2.08% Equity 97.92% Equity Sector Allocation
Sector Value Financial Services 28.51% Technology 17.15% Industrials 15.19% Consumer Cyclical 13.31% Health Care 7.82% Consumer Defensive 4.63% Utility 4.18% Energy 2.92% Real Estate 1.8% Basic Materials 1.55% Communication Services 1.42% Top Securities Holdings / Portfolio
Name Holding Value Quantity Infosys Ltd (Technology)
Equity, Since 30 Sep 13 | INFY9% ₹979 Cr 6,821,331
↑ 122,366 HDFC Bank Ltd (Financial Services)
Equity, Since 30 Apr 14 | HDFCBANK7% ₹808 Cr 5,138,677 ICICI Bank Ltd (Financial Services)
Equity, Since 31 May 17 | ICICIBANK5% ₹612 Cr 6,382,176 Larsen & Toubro Ltd (Industrials)
Equity, Since 30 Sep 20 | LT3% ₹388 Cr 1,435,051 NTPC Ltd Shs Dematerialised (Utilities)
Equity, Since 31 Mar 21 | 5325553% ₹386 Cr 17,505,739 State Bank of India (Financial Services)
Equity, Since 28 Feb 21 | SBIN3% ₹327 Cr 5,833,668 Reliance Industries Ltd (Energy)
Equity, Since 31 Aug 19 | RELIANCE3% ₹326 Cr 1,354,248 Axis Bank Ltd (Financial Services)
Equity, Since 30 Jun 20 | 5322152% ₹263 Cr 2,699,158
↓ -122,312 Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 30 Nov 16 | SUNPHARMA2% ₹262 Cr 2,356,449
↑ 174,004 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 Oct 21 | M&M2% ₹251 Cr 1,590,449
↓ -84,148
Therefore, from the above pointers, it can be said that both the schemes exhibit different attributes with respect to different parameters. However, when it comes to investing, it is always advisable that people should go through the scheme’s modalities completely before doing the actual investment. Additionally, they should also check whether the scheme’s approach is in-line with your investment objective. To get further clarification, you can even consult a financial advisor. This will help you ensure that your investment is safe as well as it paves way for wealth creation.